APA

Salar A., Domingo-Domenech E., Estany C., Canales M. A., Gallardo F., Servitje O., Fraile G. & Montalbán C. (20091228). Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. : Cancer.

Chicago

Salar Antonio, Domingo-Domenech Eva, Estany Cristina, Canales Miguel A, Gallardo Fernando, Servitje Octavio, Fraile Guadalupe and Montalbán Carlos. 20091228. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. : Cancer.

Harvard

Salar A., Domingo-Domenech E., Estany C., Canales M. A., Gallardo F., Servitje O., Fraile G. and Montalbán C. (20091228). Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. : Cancer.

MLA

Salar Antonio, Domingo-Domenech Eva, Estany Cristina, Canales Miguel A, Gallardo Fernando, Servitje Octavio, Fraile Guadalupe and Montalbán Carlos. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. : Cancer. 20091228.